Why is Mankind Pharma falling/rising?

As of 25-Aug, Mankind Pharma Ltd's stock price is currently at 2,557.45, reflecting a decrease of 52.55, or 2.01%. The stock has recently underperformed its sector by 2.42% and has experienced a trend reversal, falling after seven consecutive days of gains. It touched an intraday low of Rs 2,549.5, indicating a decline of 2.32%. Over the past week, the stock has shown a positive return of 3.33%, but it has underperformed over the past month with a decline of 1.34%. Despite a healthy long-term growth rate in net sales and operating profit, the stock's recent performance has been negatively impacted by flat results in June, including a significant drop in profit after tax compared to previous quarters.
In the broader market context, Mankind Pharma's performance contrasts with the Sensex, which has gained 0.45% over the past week. While the stock has generated a return of 8.30% over the last year, it has faced challenges with a decline in profit and a high valuation compared to its peers. The company's high management efficiency and strong ability to service debt are positive factors, but the recent fall in investor participation and liquidity concerns may have contributed to the stock's downward movement. Overall, the combination of recent poor financial results and high valuation has led to a decline in the stock price despite its historical performance.